Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.
2.

Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.

Shpakov AO, Derkach KV, Berstein LM.

Future Sci OA. 2015 Nov 1;1(3):FSO25. doi: 10.4155/fso.15.23. Review.

3.

Increased alternate splicing of Htr2c in a mouse model for Prader-Willi syndrome leads disruption of 5HT2C receptor mediated appetite.

Garfield AS, Davies JR, Burke LK, Furby HV, Wilkinson LS, Heisler LK, Isles AR.

Mol Brain. 2016 Dec 8;9(1):95.

4.

Reward-Induced Eating: Therapeutic Approaches to Addressing Food Cravings.

Rebello CJ, Greenway FL.

Adv Ther. 2016 Nov;33(11):1853-1866. Review.

5.

Behavioral, pharmacological and neuroanatomical analysis of serotonin 2C receptor agonism on maternal behavior in rats.

Wu R, Gao J, Chou S, Davis C, Li M.

Psychoneuroendocrinology. 2016 Nov;73:252-262. doi: 10.1016/j.psyneuen.2016.08.017.

PMID:
27566488
6.

Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial.

Farr OM, Upadhyay J, Gavrieli A, Camp M, Spyrou N, Kaye H, Mathew H, Vamvini M, Koniaris A, Kilim H, Srnka A, Migdal A, Mantzoros CS.

Diabetes. 2016 Oct;65(10):2943-53. doi: 10.2337/db16-0635.

PMID:
27385157
7.

CRF receptor 1 antagonism and brain distribution of active components contribute to the ameliorative effect of rikkunshito on stress-induced anorexia.

Mogami S, Sadakane C, Nahata M, Mizuhara Y, Yamada C, Hattori T, Takeda H.

Sci Rep. 2016 Jun 8;6:27516. doi: 10.1038/srep27516.

8.

Serotonin as a New Therapeutic Target for Diabetes Mellitus and Obesity.

Oh CM, Park S, Kim H.

Diabetes Metab J. 2016 Apr;40(2):89-98. doi: 10.4093/dmj.2016.40.2.89. Review.

9.

Sex difference in physical activity, energy expenditure and obesity driven by a subpopulation of hypothalamic POMC neurons.

Burke LK, Doslikova B, D'Agostino G, Greenwald-Yarnell M, Georgescu T, Chianese R, Martinez de Morentin PB, Ogunnowo-Bada E, Cansell C, Valencia-Torres L, Garfield AS, Apergis-Schoute J, Lam DD, Speakman JR, Rubinstein M, Low MJ, Rochford JJ, Myers MG, Evans ML, Heisler LK.

Mol Metab. 2016 Jan 22;5(3):245-52. doi: 10.1016/j.molmet.2016.01.005.

10.

Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism.

Roh E, Song do K, Kim MS.

Exp Mol Med. 2016 Mar 11;48:e216. doi: 10.1038/emm.2016.4. Review.

11.

The Role of PVH Circuits in Leptin Action and Energy Balance.

Sutton AK, Myers MG Jr, Olson DP.

Annu Rev Physiol. 2016;78:207-21. doi: 10.1146/annurev-physiol-021115-105347. Review.

12.

5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats.

Martin-Gronert MS, Stocker CJ, Wargent ET, Cripps RL, Garfield AS, Jovanovic Z, D'Agostino G, Yeo GS, Cawthorne MA, Arch JR, Heisler LK, Ozanne SE.

Dis Model Mech. 2016 Apr;9(4):401-12. doi: 10.1242/dmm.023903.

13.

Peripheral Serotonin: a New Player in Systemic Energy Homeostasis.

Namkung J, Kim H, Park S.

Mol Cells. 2015 Dec;38(12):1023-8. doi: 10.14348/molcells.2015.0258. Review.

14.

The 5-HT₂C receptor agonist, lorcaserin, and the 5-HT₆ receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour.

Higgs S, Cooper AJ, Barnes NM.

Psychopharmacology (Berl). 2016 Feb;233(3):417-24. doi: 10.1007/s00213-015-4112-x.

15.

Contribution of Neuroinflammation to the Pathogenesis of Cancer Cachexia.

Molfino A, Gioia G, Rossi Fanelli F, Laviano A.

Mediators Inflamm. 2015;2015:801685. doi: 10.1155/2015/801685. Review.

16.

How Does the Brain Implement Adaptive Decision Making to Eat?

Compan V, Walsh BT, Kaye W, Geliebter A.

J Neurosci. 2015 Oct 14;35(41):13868-78. doi: 10.1523/JNEUROSCI.2602-15.2015. Review. Erratum in: J Neurosci. 2016 Feb 24;36(8):2554.

17.

The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes.

Derkach KV, Bondareva VM, Chistyakova OV, Berstein LM, Shpakov AO.

Int J Endocrinol. 2015;2015:245459. doi: 10.1155/2015/245459.

18.

Weight Loss After RYGB Is Independent of and Complementary to Serotonin 2C Receptor Signaling in Male Mice.

Carmody JS, Ahmad NN, Machineni S, Lajoie S, Kaplan LM.

Endocrinology. 2015 Sep;156(9):3183-91. doi: 10.1210/en.2015-1226.

19.

A New Strategy Using Rikkunshito to Treat Anorexia and Gastrointestinal Dysfunction.

Saegusa Y, Hattori T, Nahata M, Yamada C, Takeda H.

Evid Based Complement Alternat Med. 2015;2015:364260. doi: 10.1155/2015/364260. Review.

20.

New targets to treat obesity and the metabolic syndrome.

Martin KA, Mani MV, Mani A.

Eur J Pharmacol. 2015 Sep 15;763(Pt A):64-74. doi: 10.1016/j.ejphar.2015.03.093. Review.

Items per page

Supplemental Content

Support Center